Sarepta Therapeutics (SRPT) — Entry Risk Score
Stock · re-scored every trading day · data as of 2026-11-12
The entry score measures one thing: how far Sarepta Therapeutics's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.
On 2026-11-12, Sarepta Therapeutics's price sits 2.05 ATR below its 20-day average ($18.00); it trades below its 200-day average ($18.54); its 14-day RSI is 39; it has moved -6.37% over 20 sessions; our regime filter classifies it as no confirmed trend.
Falling-knife flag: this Buy Zone score comes on top of a -16.7% decline over roughly 60 sessions. In our own data that pattern has swung harder than other Buy Zone names in both directions. See the audit.
Is Sarepta Therapeutics (SRPT) a buy right now?
Sarepta Therapeutics scores 88/98 (Buy) as of 2026-11-12; it is 32.8% below its 52-week high of $23.83; it is below its 200-day average; it moved -10.16% over the last 5 sessions. A high score means our model rates today's price as a favorable, defined-risk entry, based on where it sits versus its 20-day average after adjusting for trend and volatility. It is not a prediction that the price will rise. It also carries a falling-knife flag (down 16.7% over ~60 sessions). Not investment advice.
Score history
Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.
| Date | Score | Δ | Close |
|---|---|---|---|
| 2026-11-12 | 88 | +12 | $16.01 |
| 2026-11-06 | 76 | -4 | $17.82 |
| 2026-11-05 | 80 | +3 | $17.57 |
| 2026-11-04 | 77 | +7 | $18.99 |
| 2026-11-03 | 70 | -4 | $18.54 |
| 2026-11-02 | 74 | -2 | $18.32 |
| 2026-10-29 | 76 | +4 | $19.23 |
| 2026-10-28 | 72 | -5 | $19.32 |
| 2026-10-27 | 77 | +5 | $18.89 |
| 2026-10-26 | 72 | -5 | $17.98 |
| 2026-10-23 | 77 | +4 | $17.73 |
| 2026-10-22 | 73 | -2 | $18.18 |
Related stocks
See today's full rankings + entry plan for SRPT →Get the Sunday Brief
One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.